Company Filing History:
1 out of 88 
1 out of 4 Years Active: 2020
Title: Laurin Wimmer: Innovator in Neuropsychiatric Treatment
Introduction
Laurin Wimmer is a notable inventor based in Oberndorf, Austria. He has made significant contributions to the field of neuropsychiatric disorders through his innovative research and development of novel compounds.
Latest Patents
Wimmer holds a patent for "Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of use." This patent includes novel pyrazolo-quinolinone compounds and outlines methods for using these compounds to treat various disorders. These disorders include schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive-compulsive disorder, panic disorder, Huntington's disease, nocturnal enuresis, depression, temporomandibular myofascial pain, trigeminal nerve disorders, migraine, and tinnitus. He has 1 patent to his name.
Career Highlights
Throughout his career, Wimmer has worked with esteemed organizations such as the UWM Research Foundation, Inc. and the Medical University of Vienna. His work has focused on developing treatments that address complex neuropsychiatric conditions.
Collaborations
Wimmer has collaborated with notable individuals in his field, including James M. Cook and Daniel Knutson. These collaborations have contributed to the advancement of his research and the development of effective treatments.
Conclusion
Laurin Wimmer's innovative work in the field of neuropsychiatric treatment highlights his commitment to improving the lives of individuals affected by various disorders. His contributions through patents and collaborations continue to pave the way for future advancements in this critical area of medicine.